Yu-Tzu Tai

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 39

Top Venues

Blood cancer journal

Clinical cancer research : an official journal of the American Association for Cancer Research

Leukemia

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Mehmet Kemal Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu, Eugenio Morelli, Annamaria Gulla, Yu-Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C Anderson
BRD9 degradation disrupts ribosome biogenesis in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Mehmet Kemal Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu, Eugenio Morelli, Annamaria Gulla, Yu-Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C Anderson
BRD9 degradation disrupts ribosome biogenesis in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Ola Rizq, Naoya Mimura, Motohiko Oshima, Shuji Momose, Naoya Takayama, Naoki Itokawa, Shuhei Koide, Asuka Shibamiya, Yurie Miyamoto-Nagai, Mohamed Rizk, Yaeko Nakajima-Takagi, Kazumasa Aoyama, Changshan Wang, Atsunori Saraya, Masanori Seimiya, Mariko Watanabe, Satoshi Yamasaki, Tatsuhiro Shibata, Kiyoshi Yamaguchi, Yoichi Furukawa, Tetsuhiro Chiba, Emiko Sakaida, Chiaki Nakaseko, Jun-Ichi Tamaru, Yu-Tzu Tai, Kenneth C Anderson, Hiroaki Honda, Atsushi Iwama
UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease. Leukemia (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Mehmet Kemal Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu, Eugenio Morelli, Annamaria Gulla, Yu-Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C Anderson
BRD9 degradation disrupts ribosome biogenesis in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Mehmet Kemal Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu, Eugenio Morelli, Annamaria Gulla, Yu-Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C Anderson
BRD9 degradation disrupts ribosome biogenesis in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Ola Rizq, Naoya Mimura, Motohiko Oshima, Shuji Momose, Naoya Takayama, Naoki Itokawa, Shuhei Koide, Asuka Shibamiya, Yurie Miyamoto-Nagai, Mohamed Rizk, Yaeko Nakajima-Takagi, Kazumasa Aoyama, Changshan Wang, Atsunori Saraya, Ryoji Ito, Masanori Seimiya, Mariko Watanabe, Satoshi Yamasaki, Tatsuhiro Shibata, Kiyoshi Yamaguchi, Yoichi Furukawa, Tetsuhiro Chiba, Emiko Sakaida, Chiaki Nakaseko, Jun-Ichi Tamaru, Yu-Tzu Tai, Kenneth C Anderson, Hiroaki Honda, Atsushi Iwama
Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease. Leukemia (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Shih-Feng Cho, Kenneth C Anderson, Yu-Tzu Tai
Microenvironment Is a Key Determinant of Immune Checkpoint Inhibitor Response. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Sophia Adamia, Shruti Bhatt, Kenneth Wen, Zuzana Chyra, Geoffrey G Fell, Yu-Tzu Tai, Marisa S Pioso, Ivane Abiatari, Anthony G Letai, David M Dorfman, Teru Hideshima, Kenneth C Anderson
Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma. Leukemia 36 (4) (2022)
Arghya Ray, Yan Song, Ting Du, Leutz Buon, Yu-Tzu Tai, Dharminder Chauhan, Kenneth C Anderson
Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma. Blood cancer journal 12 (4) (2022)
Hailin Chen, Tengteng Yu, Liang Lin, Lijie Xing, Shih-Feng Cho, Kenneth Wen, Kimberly Aardalen, Adwait Oka, Joni Lam, Mike Daley, Haihui Lu, Nikhil C Munshi, Kenneth C Anderson, Yu-Tzu Tai
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation. Blood cancer journal 12 (8) (2022)
Mark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, Robert A Redd, Eileen Mary Boyle, Benny Zhitomirsky, Andrew J Dunford, Yu-Tzu Tai, Selina J Chavda, Cody Boehner, Carl Jannes Neuse, Mahshid Rahmat, Andrew T Hutchinson, Tineke Casneuf, Raluca Verona, Efstathis Kastritis, Lorenzo Trippa, Chip Stewart, Brian A Walker, Faith E Davies, Meletios- Athanasios Dimopoulos, Peter Leif Bergsagel, Kwee L Yong, Gareth J Morgan, François Aguet, Gad A Getz, Irene M Ghobrial
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes. Nature communications 13 (1) (2022)
Giada Bianchi, Peter G Czarnecki, Matthew Ho, Aldo M Roccaro, Antonio Sacco, Yawara Kawano, Annamaria Gullà, Anil Aktas Samur, Tianzeng Chen, Kenneth Wen, Yu-Tzu Tai, Maria Moscvin, Xinchen Wu, Gulden Camci-Unal, Matteo Claudio Da Via, Niccolo' Bolli, Tomasz Sewastianik, Ruben D Carrasco, Irene M Ghobrial, Kenneth C Anderson
ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment. Blood cancer discovery 2 (4) (2022)
Mehmet Kemal Samur, Maria Teresa Fulciniti, Anil Aktas Samur, Abdul-Hamid Bazarbachi, Yu-Tzu Tai, Rao Prabhala, Alejandro Alonso, Adam S Sperling, Timothy Campbell, Fabio Petrocca, Kristen Hege, Shari Kaiser, Hervé Avet Loiseau, Kenneth C Anderson, Nikhil C Munshi
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma. Nature communications 12 (1) (2021)
Jiye Liu, Teru Hideshima, Lijie Xing, Su Wang, Wenrong Zhou, Mehmet Kemal Samur, Tomasz Sewastianik, Daisuke Ogiya, Gang An, Shaobing Gao, Li Yang, Tong Ji, Giada Bianchi, Kenneth Wen, Yu-Tzu Tai, Nikhil Munshi, Paul Gerard Richardson, Ruben Carrasco, Yong Cang, Kenneth C Anderson
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment. Science advances 7 (23) (2021)
Lijie Xing, Su Wang, Jiye Liu, Tengteng Yu, Hailin Chen, Kenneth Wen, Yuyin Li, Liang Lin, Phillip A Hsieh, Shih-Feng Cho, Gang An, Lugui Qiu, Krista Kinneer, Nikhil Munshi, Kenneth C Anderson, Yu-Tzu Tai
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Subodh Kumar, Leutz Buon, Srikanth Talluri, Marco Roncador, Chengcheng Liao, Jiangning Zhao, Jialan Shi, Chandraditya Chakraborty, Gabriel Gonzalez, Yu-Tzu Tai, Rao Prabhala, Mehmet Kemal Samur, Nikhil C Munshi, Masood A Shammas
Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma. Communications biology 4 (1) (2021)
Shih-Feng Cho, Lijie Xing, Kenneth C Anderson, Yu-Tzu Tai
Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma. Cancers 13 (23) (2021)
Jooeun Bae, Fabrizio Accardi, Teru Hideshima, Yu-Tzu Tai, Rao Prabhala, Aaron Shambley, Kenneth Wen, Sean Rowell, Paul Gerard Richardson, Nikhil C Munshi, Kenneth C Anderson
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma. Leukemia (2021)
Nisha S Joseph, Yu-Tzu Tai, Kenneth C Anderson, Sagar Lonial
Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor. Clinical pharmacology : advances and applications 13 (2021)
Tengteng Yu, Chenxing Du, Xiaoke Ma, Weiwei Sui, Zhen Yu, Lanting Liu, Lei Zhao, Zhongqing Li, Jie Xu, Xiaojing Wei, Wen Zhou, Shuhui Deng, Dehui Zou, Gang An, Yu-Tzu Tai, Guido Tricot, Kenneth C Anderson, Lugui Qiu, Fenghuang Zhan, Mu Hao
Polycomb-like Protein 3 Induces Proliferation and Drug Resistance in Multiple Myeloma and Is Regulated by miRNA-15a. Molecular cancer research : MCR 18 (7) (2020)
Tengteng Yu, Bharat Chaganty, Liang Lin, Lijie Xing, Boopathy Ramakrishnan, Kenneth Wen, Phillip A Hsieh, Andrew Wollacott, Karthik Viswanathan, Hedy Adari, Shih-Feng Cho, Yuyin Li, Hailin Chen, Wenjuan Yang, Lian Xu, Gang An, Lugui Qiu, Nikhil Munshi, Gregory Babcock, Zachary Shriver, James R Myette, Kenneth C Anderson, Yu-Tzu Tai
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo. Blood cancer journal 10 (11) (2020)
Liang Lin, Shih-Feng Cho, Lijie Xing, Kenneth Wen, Yuyin Li, Tengteng Yu, Phillip A Hsieh, Hailin Chen, Metin Kurtoglu, Yi Zhang, C Andrew Stewart, Nikhil Munshi, Kenneth C Anderson, Yu-Tzu Tai
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma. Leukemia 35 (3) (2020)
Omar Nadeem, Yu-Tzu Tai, Kenneth C Anderson
Immunotherapeutic and Targeted Approaches in Multiple Myeloma. ImmunoTargets and therapy 9 (2020)
Krista Kinneer, John Meekin, Arnaud C Tiberghien, Yu-Tzu Tai, Sandrina Phipps, Christine Mione Kiefer, Marlon C Rebelatto, Nazzareno Dimasi, Alyssa Moriarty, Kyriakos P Papadopoulos, Sriram Sridhar, Stephen J Gregson, Michael J Wick, Luke Masterson, Kenneth C Anderson, Ronald Herbst, Philip W Howard, David A Tice
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (24) (2018)
Li Yin, Ashujit Tagde, Reddy Gali, Yu-Tzu Tai, Teru Hideshima, Kenneth Anderson, David Avigan, Donald W Kufe
MUC1-C is a target in lenalidomide resistant multiple myeloma. British journal of haematology 178 (6) (2017)

Yu-Tzu Tai.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yu-Tzu Tai